Pavmed Inc Stock Analysis
PAVM Stock | USD 1.00 0.01 0.99% |
PAVmed Inc is undervalued with Real Value of 1.43 and Target Price of 2.73. The main objective of PAVmed stock analysis is to determine its intrinsic value, which is an estimate of what PAVmed Inc is worth, separate from its market price. There are two main types of PAVmed's stock analysis: fundamental analysis and technical analysis.
The PAVmed stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. PAVmed is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. PAVmed Stock trading window is adjusted to America/New York timezone.
PAVmed |
PAVmed Stock Analysis Notes
About 15.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.14. PAVmed Inc had not issued any dividends in recent years. The entity had 1:15 split on the 7th of December 2023. PAVmed Inc. operates as a medical device company in the United States. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York. Pavmed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 89 people. To find out more about PAVmed Inc contact Lishan MD at 917-813-1828 or learn more at https://www.pavmed.com.PAVmed Inc Investment Alerts
PAVmed Inc is way too risky over 90 days horizon | |
PAVmed Inc has some characteristics of a very speculative penny stock | |
PAVmed Inc appears to be risky and price may revert if volatility continues | |
PAVmed Inc has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 2.45 M. Net Loss for the year was (64.17 M) with loss before overhead, payroll, taxes, and interest of (3.24 M). | |
PAVmed Inc currently holds about 68.47 M in cash with (52.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. | |
PAVmed Inc has a poor financial position based on the latest SEC disclosures | |
Latest headline from finance.yahoo.com: Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health Services Forum |
PAVmed Inc Upcoming and Recent Events
12th of March 2024 Upcoming Quarterly Report | View | |
21st of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
12th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
PAVmed Largest EPS Surprises
Earnings surprises can significantly impact PAVmed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2020-11-06 | 2020-09-30 | -0.1 | -0.11 | -0.01 | 10 | ||
2016-08-12 | 2016-06-30 | -0.09 | -0.1 | -0.01 | 11 | ||
2023-11-13 | 2023-09-30 | -0.14 | -0.16 | -0.02 | 14 |
PAVmed Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Tower Research Capital Llc | 2024-06-30 | 9.7 K | Ubs Group Ag | 2024-06-30 | 4.8 K | Cwm, Llc Duplicate | 2024-06-30 | 4.7 K | Wells Fargo & Co | 2024-06-30 | 3.9 K | Atlantic Trust Group, Llc | 2024-06-30 | 836 | Hanson Mcclain Inc | 2024-09-30 | 447 | Advisor Group Holdings, Inc. | 2024-06-30 | 116 | Bank Of America Corp | 2024-06-30 | 79.0 | Parallel Advisors, Llc | 2024-06-30 | 78.0 | First Manhattan Co. Llc | 2024-09-30 | 600 K | Vanguard Group Inc | 2024-09-30 | 281 K |
PAVmed Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.74 M.PAVmed Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.02) | (2.13) | |
Return On Capital Employed | 3.27 | 3.10 | |
Return On Assets | (1.94) | (2.03) | |
Return On Equity | 1.19 | 1.13 |
Management Efficiency
PAVmed Inc has return on total asset (ROA) of (0.8007) % which means that it has lost $0.8007 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (13.5806) %, meaning that it created substantial loss on money invested by shareholders. PAVmed's management efficiency ratios could be used to measure how well PAVmed manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of November 2024, Return On Tangible Assets is likely to drop to -2.13. In addition to that, Return On Capital Employed is likely to drop to 3.10. At this time, PAVmed's Non Current Assets Total are very stable compared to the past year. As of the 24th of November 2024, Asset Turnover is likely to grow to 0.08, while Total Assets are likely to drop about 23.6 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | (3.32) | (3.16) | |
Tangible Book Value Per Share | (3.52) | (3.34) | |
Enterprise Value Over EBITDA | (0.78) | (0.82) | |
Price Book Value Ratio | (0.55) | (0.58) | |
Enterprise Value Multiple | (0.78) | (0.82) | |
Price Fair Value | (0.55) | (0.58) | |
Enterprise Value | 58.9 M | 62 M |
The leadership approach at PAVmed's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Operating Margin (13.98) | Beta 0.693 | Return On Assets (0.80) | Return On Equity (13.58) |
Technical Drivers
As of the 24th of November, PAVmed holds the Mean Deviation of 5.5, coefficient of variation of 944.32, and Market Risk Adjusted Performance of (0.99). Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of PAVmed, as well as the relationship between them. Please check PAVmed Inc jensen alpha and downside variance to decide if PAVmed Inc is priced more or less accurately, providing market reflects its current price of 1.0 per share. Given that PAVmed is a hitting penny stock territory we advise to closely look at its total risk alpha.PAVmed Inc Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. PAVmed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for PAVmed Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
PAVmed Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PAVmed insiders, such as employees or executives, is commonly permitted as long as it does not rely on PAVmed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PAVmed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
PAVmed Outstanding Bonds
PAVmed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PAVmed Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PAVmed bonds can be classified according to their maturity, which is the date when PAVmed Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
PAVmed Predictive Daily Indicators
PAVmed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PAVmed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
PAVmed Forecast Models
PAVmed's time-series forecasting models are one of many PAVmed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PAVmed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About PAVmed Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how PAVmed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PAVmed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PAVmed. By using and applying PAVmed Stock analysis, traders can create a robust methodology for identifying PAVmed entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (32.33) | (33.94) | |
Operating Profit Margin | (28.06) | (29.46) | |
Net Loss | (26.17) | (27.48) | |
Gross Profit Margin | (1.62) | (1.70) |
Current PAVmed Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PAVmed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PAVmed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
2.73 | Buy | 3 | Odds |
Most PAVmed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand PAVmed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of PAVmed Inc, talking to its executives and customers, or listening to PAVmed conference calls.
PAVmed Stock Analysis Indicators
PAVmed Inc stock analysis indicators help investors evaluate how PAVmed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading PAVmed shares will generate the highest return on investment. By understating and applying PAVmed stock analysis, traders can identify PAVmed position entry and exit signals to maximize returns.
Begin Period Cash Flow | 39.7 M | |
Common Stock Shares Outstanding | 7.2 M | |
Total Stockholder Equity | -53.8 M | |
Property Plant And Equipment Net | 6 M | |
Cash And Short Term Investments | 19.6 M | |
Cash | 19.6 M | |
Accounts Payable | 1.8 M | |
Net Debt | 29.1 M | |
50 Day M A | 1.17 | |
Total Current Liabilities | 54.2 M | |
Other Operating Expenses | 71.2 M | |
Non Current Assets Total | 8.6 M | |
Non Currrent Assets Other | 1.1 M | |
Stock Based Compensation | 11.1 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.